Report Description

Forecast Period


Market Size (2024)

USD 314.11 Million

CAGR (2025-2030)


Fastest Growing Segment


Largest Market

West India

Market Size (2030)

USD 484.49 Million

Market Overview

India Respiratory Inhalers Market was valued at USD 314.11 Million in 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 7.45% through 2030. The India Respiratory Inhalers Market encompasses a robust industry involved in the manufacturing and distribution of respiratory inhalers within the vast and diverse landscape of India. These indispensable devices, designed to deliver medication directly to the lungs, play a crucial role in improving the quality of life for patients battling respiratory ailments such as asthma, Chronic Obstructive Pulmonary Disease (COPD), and various other lung-related diseases. The market's size and growth are influenced by a multitude of factors, including the prevalence of respiratory diseases in the population, the level of awareness regarding available treatments, and the overall healthcare infrastructure. With India grappling with increasing pollution levels, urbanization, and a continuously growing population, the demand for respiratory inhalers is poised to witness a significant surge. This surge not only stems from the need for effective treatment options but also underlines the importance of preventive measures to maintain respiratory health.

The rise in environmental pollution, occupational hazards, and lifestyle changes contribute to the growing burden of respiratory diseases in India. As a result, there is a pressing need for innovative and advanced respiratory inhalers that can cater to the specific needs of patients and provide efficient drug delivery. The market is witnessing a shift towards more patient-centric and user-friendly inhaler devices, incorporating features like dose counters, smart sensors, and breath-actuated mechanisms. In addition to the increasing demand within the domestic market, the India Respiratory Inhalers Market also holds immense potential for export opportunities. With a strong manufacturing base, skilled workforce, and favorable government initiatives, India can emerge as a global hub for respiratory inhaler production and supply. The India Respiratory Inhalers Market presents promising opportunities for market expansion and growth in the near future. As healthcare providers and industry stakeholders focus on enhancing access to quality care, improving patient outcomes, and addressing the unmet needs of the population, the market is expected to witness significant advancements in technology, innovation, and therapeutic options.

Key Market Drivers

Increasing Prevalence of Respiratory Disorders

The escalating prevalence of respiratory disorders in India is significantly driving the demand for respiratory inhalers. Respiratory ailments, including asthma, chronic obstructive pulmonary disorder (COPD), and other lung diseases, are becoming increasingly common due to factors such as escalating pollution levels, changing lifestyles, and a rise in smoking habits. This rise in respiratory disorders has put a burden on the healthcare system, with the World Health Organization estimating that around 15-20% of India's population suffers from some form of respiratory disorder.

To address this growing need, there is an urgent requirement for effective medical equipment such as inhalers. Inhalers offer a convenient and effective mode of drug delivery directly to the lungs, providing immediate relief to patients. They are portable, easy to use, and ensure a quicker onset of action compared to oral medications. This makes them a crucial part of respiratory disease management, helping patients breathe easier and manage their condition more effectively. With the increasing awareness of the benefits of inhalers and the rising incidence of respiratory diseases in India, the respiratory inhaler market is experiencing notable growth. This growth is driven by the need for better management of respiratory disorders and the recognition of inhalers as an essential component of healthcare for those affected. As the demand for respiratory inhalers continues to rise, the industry is focused on developing innovative solutions to meet the evolving needs of patients and improve their quality of life.

Expanding Technological Advancements

In India, the escalating influence of technological advancements has a direct correlation with the rising demand for respiratory inhalers. As the country grapples with the detrimental effects of air pollution, there has been a stark increase in respiratory disorders like asthma and COPD. This alarming trend has accentuated the urgent need for efficient and user-friendly inhalers that can alleviate the burden on patients. Technology has emerged as a key player in addressing this pressing need. The introduction of smart inhalers equipped with digital sensors has revolutionized the field of respiratory care. These innovative devices not only ensure enhanced drug delivery but also enable adherence monitoring and provide critical health analytics. By connecting these inhalers to smartphones, patients and healthcare providers can access real-time data about the patient's usage and condition, empowering them to make informed decisions.

The advent of telemedicine platforms has further transformed respiratory care by facilitating home-based treatment. Inhalers equipped with advanced technology have become an integral part of this shift towards remote healthcare. The convenience and improved efficacy offered by these tech-equipped inhalers have resulted in their heightened demand among patients and healthcare professionals alike. Recognizing the potential of health-tech solutions, policymakers in India are revising regulations to encourage the adoption of digital health. This supportive environment not only propels the demand for respiratory inhalers but also fosters innovation in the healthcare landscape. The interplay between expanding technological advancements and the increasing demand for respiratory inhalers in India is thus becoming more evident, with technology serving as a catalyst for improved respiratory care and overall well-being.

Increasing Applications in Home care Settings

The demand for respiratory inhalers in India has seen a significant upsurge in recent years, primarily driven by their increasing applications in home care settings. With the ease of use and the capacity to administer medication effectively, inhalers have become the preferred choice for many households. This is particularly relevant in the context of India's burgeoning population, where home care solutions provide practicality and convenience for individuals with respiratory disorders.

India's air quality index is often compromised due to pollution, leading to a rise in respiratory disorders such as asthma, chronic obstructive pulmonary disease (COPD), and allergies. These conditions necessitate the use of respiratory inhalers for symptom management and treatment. The ongoing COVID-19 pandemic has further underscored the importance of respiratory health, resulting in a heightened awareness and demand for respiratory aids, including inhalers. Additionally, the Indian pharmaceutical sector's advancements have contributed to the production of cost-effective inhalers, making them accessible to a larger section of the population. With continued focus on healthcare infrastructure and awareness, the demand for respiratory inhalers in home care settings in India is expected to sustain its growth trajectory, ensuring that individuals receive the necessary care and support for their respiratory well-being.

Increasing Adoption of Smart Inhalers Technologies

The burgeoning adoption of smart inhaler technologies in India is causing a significant surge in the demand for respiratory inhalers. These advanced medical devices, which incorporate digital technology to monitor and manage respiratory conditions, are becoming increasingly popular due to their efficacy and convenience. As the prevalence of respiratory diseases such as asthma and COPD rises in the country, the need for effective treatment strategies is escalating. Smart inhalers, with their user-friendly design and real-time data tracking capabilities, are seen as a revolutionary solution. They offer patients and healthcare providers valuable insights into the disease's progression and the effectiveness of treatment, enabling personalized care.

The steady expansion of the digital healthcare infrastructure in India, aided by government initiatives and increased internet penetration, is facilitating the adoption of smart inhaler technologies. The growing awareness of these devices among patients and healthcare professionals also contributes to their escalating demand. Thus, the intersection of technological advancement and healthcare necessity is pushing the uptake of respiratory inhalers to new heights in India. In addition to these factors, the affordability and accessibility of smart inhalers are crucial drivers of their increasing demand. With advancements in manufacturing and distribution, smart inhalers are becoming more affordable and widely available to patients across different socioeconomic backgrounds. This democratization of access to advanced respiratory care empowers individuals to take control of their health and improve their quality of life.

The integration of telemedicine and remote patient monitoring has further enhanced the value and convenience of smart inhalers. Patients can now easily connect with healthcare professionals, receive real-time feedback, and access personalized treatment plans from the comfort of their own homes. This shift towards remote healthcare has become especially significant in the current global scenario, where virtual consultations and remote monitoring have gained prominence. Overall, the increasing demand for respiratory inhalers in India is driven by a combination of factors, including the rising prevalence of respiratory diseases, advancements in digital healthcare infrastructure, growing awareness among patients and healthcare professionals, affordability and accessibility, and the integration of telemedicine. As these trends continue to evolve, the adoption of smart inhaler technologies is expected to grow further, revolutionizing respiratory care and improving outcomes for individuals across the country.


Download Free Sample Report

Key Market Challenges

High Cost of Devices

In India, the high cost of respiratory inhalers is a significant factor contributing to a decrease in their demand. A majority of the Indian population resides in rural areas where levels of income and affordability are considerably low. The cost of respiratory inhalers, which are essential for the management of respiratory diseases such as asthma and COPD, is often prohibitive for this demographic. The high price point is primarily driven by the import-dependent nature of the Indian market for these devices. Furthermore, the lack of insurance coverage for such devices exacerbates the problem, making these life-saving devices inaccessible to a large portion of the population. Additionally, the GST rate on medical equipment, including inhalers, is set at 12% - a significant amount for those with lower income. These factors collectively contribute to the decreased demand for respiratory inhalers in India. The need of the hour is regulatory intervention to make these devices more affordable, thereby increasing their accessibility and demand.

Lack Of Knowledge of Device

The demand for respiratory inhalers in India suffers due to a critical barrier: the lack of knowledge on device usage among the general populace. Despite the growing prevalence of respiratory disorders such as asthma and COPD, many individuals remain unfamiliar with the proper utilization of these life-saving tools, resulting in decreased demand and adoption. Fear, misconceptions, and a general lack of understanding about these devices often deter potential users. Education and awareness programs are currently lacking, and healthcare professionals may not have the necessary time or resources to adequately instruct patients. This gap in knowledge and understanding exacerbates the health crisis, as individuals suffering from respiratory diseases may not seek appropriate treatment, thereby further reducing demand for inhalers. To address this issue, robust patient education initiatives are vital. These should focus on demonstrating the proper use of inhalers, clarifying misconceptions, and emphasizing the importance and benefits of regular use. With concerted efforts in patient education and awareness, we can anticipate an increase in demand for respiratory inhalers in the Indian market.

Key Market Trends

Alarming Rise in Air Pollution

The alarming rise in air pollution in India has led to a significant increase in the demand for respiratory inhalers. This surge is primarily driven by the escalating levels of particulate matter and harmful pollutants in the air that pose severe health risks, especially respiratory problems. The World Health Organization (WHO) reports that many Indian cities consistently rank among the world's most polluted, with fine particulate matter levels far exceeding safe limits. This worsening air quality directly correlates with a rise in asthma cases, chronic obstructive pulmonary disorder (COPD), and other respiratory ailments, subsequently leading to a heightened demand for inhalers.

To address this growing concern, the healthcare sector in India has responded by ramping up the production and distribution of these vital medical devices. Manufacturers are investing in research and development to innovate inhaler technology, making them more efficient and user-friendly. Additionally, public awareness campaigns about the dangers of air pollution have gained momentum, with organizations and government bodies actively educating the public about the adverse effects of polluted air on respiratory health. This increased awareness has contributed to the growing demand for inhalers, as more individuals recognize the necessity of respiratory aids in minimizing the health risks associated with polluted air.

The market for respiratory inhalers in India is not only driven by the rise in pollution-related respiratory ailments but also by factors such as changing lifestyles and an aging population. Urbanization and industrialization have led to increased exposure to pollutants, while sedentary lifestyles and unhealthy habits have made individuals more susceptible to respiratory issues. Additionally, the aging population requires more healthcare support, including respiratory aids, to manage chronic conditions and maintain a good quality of life. The unprecedented growth of the respiratory inhaler market in India underscores the urgent need for effective pollution control measures. Government bodies, environmental organizations, and industry stakeholders are working together to implement stricter emission standards, promote renewable energy sources, and encourage sustainable practices. These measures aim to reduce the levels of pollutants in the air and improve overall air quality, ultimately mitigating the health risks faced by millions of individuals.

The alarming rise in air pollution in India has created a pressing need for respiratory inhalers. The combination of increasing pollution levels, rising awareness about the health risks, and the growing prevalence of respiratory ailments has fueled the demand for these essential medical devices. The healthcare sector, along with public awareness campaigns, is actively addressing this challenge by increasing production, advancing technology, and promoting pollution control measures. As India strives for cleaner air and better respiratory health, the market for respiratory inhalers is expected to continue its unparalleled growth, emphasizing the importance of effective pollution control measures for the well-being of the population.

Increasing Number of Product Approvals for Respiratory Inhalers

The rapidly growing prevalence of respiratory diseases in India, coupled with an increasing number of product approvals for respiratory inhalers, has led to a significant rise in the demand for these critical healthcare devices. Asthma, Chronic Obstructive Pulmonary Disease (COPD), and other respiratory conditions are becoming increasingly common in India due to factors such as air pollution and smoking. As such, the country's regulatory bodies have been accelerating the approval process for innovative and effective respiratory inhalers, recognizing the urgent need for efficacious treatment options. These approvals have broadened the range of available inhaler devices in the market, providing patients and healthcare professionals with a diverse variety of options tailored to individual needs and preferences. In addition, the approval of these products has also stimulated competition among manufacturers, leading to advancements in inhaler technology and subsequent improvements in patient care and outcomes. Moreover, these developments have increased health awareness among the Indian population, further driving the demand for respiratory inhalers. Consequently, the Indian respiratory inhaler market is witnessing a rapid rise in demand and is anticipated to maintain this growth trajectory for the foreseeable future.

Segmental Insights

Product Type Insights

Based on the product type, it is anticipated that the Metered Dose Inhaler (MDI) will continue to dominate the respiratory inhalers market in India. The MDI's prevalence in the market can be attributed to its easy-to-use design, affordability, and wide availability across various healthcare settings. This type of inhaler delivers a precise and controlled amount of medication to the lungs in aerosol form, ensuring effective treatment for patients with respiratory conditions such as asthma and Chronic Obstructive Pulmonary Disease (COPD). The MDI's user-friendly features, including its compact size and intuitive operation, make it a preferred choice among both healthcare professionals and patients in India. Additionally, the wide range of medications available in MDI format further contributes to its popularity and widespread adoption in managing respiratory ailments. With its proven efficacy and convenience, the Metered Dose Inhaler continues to play a crucial role in improving the quality of life for individuals facing respiratory challenges in the Indian population.

Technology Insights

Based on technology, digitally operated inhalers are projected to dominate over manually operated ones. This shift is largely influenced by the integration of advanced technology in healthcare, which allows for precise dosage control, improved patient adherence, and real-time tracking of medication use. These innovative features not only enhance patient outcomes but also streamline the overall management of respiratory conditions. With digitally operated inhalers, healthcare providers can monitor treatment progress more effectively, while patients can conveniently track their medication usage and receive timely reminders for optimal therapy. This comprehensive approach to respiratory care promotes better patient engagement and empowers individuals to take control of their health. As a result, digitally operated inhalers have become the preferred choice for both healthcare providers and patients in India's evolving healthcare landscape.


Download Free Sample Report

Regional Insights

The Western region of India, particularly the metropolitan cities like Mumbai and Pune, stands out as the dominant force in the India Respiratory Inhalers Market. This can be attributed to several factors that have contributed to its prominence. Firstly, the alarming increase in pollution levels in these areas has led to a surge in the demand for respiratory inhalers. Additionally, the rise in smoking habits among the population has further fueled the need for effective respiratory treatments. Moreover, the densely populated nature of these cities has resulted in a higher prevalence of respiratory diseases, necessitating the use of inhalers for managing and alleviating symptoms.

The Western region's dominance can also be attributed to the presence of major pharmaceutical companies that have established a strong foothold in these areas. These companies have been at the forefront of research and development, continuously innovating and introducing advanced respiratory inhalers to cater to the specific needs of the population. Additionally, the region boasts better healthcare infrastructure, with state-of-the-art medical facilities and specialized clinics dedicated to respiratory care. The Western region of India, with its increasing pollution levels, smoking habits, and higher prevalence of respiratory diseases, coupled with the presence of major pharmaceutical companies and better healthcare infrastructure, has emerged as the undeniable powerhouse in the India Respiratory Inhalers Market.

Recent Developments

  • In November 2023, Cipla demonstrated a dedication to raising awareness about asthma and dispelling common myths and misunderstandings about its treatment. This commitment reflects Cipla's broader mission to enable individuals to embrace a #BerokZindagi, symbolizing a resilient life. Over the last five years, this campaign has garnered more than 100 crore views. In its latest phase, Cipla launched a film titled “Berok Zindagi ke liye bas common sense he kaafi hai”. The campaign film emphasizes the critical importance of proactive medical intervention as the foundation for effective, long-term management of respiratory conditions like asthma.

Key Market Players

  • Philips India Limited
  • Cipla Limited
  • Teva API India Limited
  • AstraZeneca Pharma India Limited
  • GlaxoSmithKline Pharmaceuticals Limited
  • Omron Healthcare India Private Limited
  • Novartis India Limited
  • 3M India Limited
  • Glenmark Pharmaceuticals Limited
  • Merck Life Science Private Limited

 By Product Type

By Technology

By Disease Indication

By Distribution Channel

By End User

By Region

  • Dry Powder Inhaler
  • Metered Dose Inhaler
  • Others
  • Manually Operated Inhalers
  • Digitally Operated Inhalers
  • COPD
  • Asthma
  • Pulmonary Atrial Hypertension
  • Others
  • Online
  • Offline
  • Hospitals & Clinics
  • Homecare
  • Others
  • North
  • South
  • West
  • East


Report Scope:

In this report, the India Respiratory Inhalers Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

  • India Respiratory Inhalers Market, By Product Type:

o   Dry Powder Inhaler

o   Metered Dose Inhaler

o   Others

  • India Respiratory Inhalers Market, By Technology:

o   Manually Operated Inhalers

o   Digitally Operated Inhalers

  • India Respiratory Inhalers Market, By Disease Indication:

o   COPD

o   Asthma

o   Pulmonary Atrial Hypertension

o   Others

  • India Respiratory Inhalers Market, By Distribution Channel:

o   Online

o   Offline

  • India Respiratory Inhalers Market, By End User:

o   Hospitals & Clinics

o   Homecare

o   Others

  • India Respiratory Inhalers Market, By Region:

o   North

o   South

o   West

o   East

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the India Respiratory Inhalers Market.

Available Customizations:

India Respiratory Inhalers Market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

India Respiratory Inhalers Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1.    Product Overview

1.1.  Market Definition

1.2.  Scope of the Market

1.2.1.    Markets Covered

1.2.2.    Years Considered for Study

1.2.3.    Key Market Segmentations

2.    Research Methodology

2.1.  Objective of the Study

2.2.  Baseline Methodology

2.3.  Key Industry Partners

2.4.  Major Association and Secondary Sources

2.5.  Forecasting Methodology

2.6.  Data Triangulation & Validations

2.7.  Assumptions and Limitations

3.    Executive Summary

3.1.  Overview of the Market

3.2.  Overview of Key Market Segmentations

3.3.  Overview of Key Market Players

3.4.  Overview of Key Regions/Countries

3.5.  Overview of Market Drivers, Challenges, Trends

4.    Voice of Customer

5.    India Respiratory Inhalers Market Outlook

5.1.  Market Size & Forecast

5.1.1.    By Value

5.2.  Market Share & Forecast

5.2.1.    By Product Type (Dry Powder Inhaler, Metered Dose Inhaler, Others)

5.2.2.    By Technology (Manually Operated Inhalers, Digitally Operated Inhalers)

5.2.3.    By Disease Indication (COPD, Asthma, Pulmonary Atrial Hypertension, Others)

5.2.4.    By Distribution Channel (Online, Offline)

5.2.5.    By End User (Hospitals & Clinics, Homecare, Others)

5.2.6.    By Region
        By State (Top 3 States)

5.2.7.    By Company (2024)

5.3.  Market Map

6.    North India Respiratory Inhalers Market Outlook

6.1.  Market Size & Forecast

6.1.1.    By Value

6.2.  Market Share & Forecast

6.2.1.    By Product Type

6.2.2.    By Technology

6.2.3.    By Disease Indication

6.2.4.    By Distribution Channel

6.2.5.    By End User

7.    West India Respiratory Inhalers Market Outlook

7.1.  Market Size & Forecast

7.1.1.    By Value

7.2.  Market Share & Forecast

7.2.1.    By Product Type

7.2.2.    By Technology

7.2.3.    By Disease Indication

7.2.4.    By Distribution Channel

7.2.5.    By End User

8.    South India Respiratory Inhalers Market Outlook

8.1.  Market Size & Forecast

8.1.1.    By Value

8.2.  Market Share & Forecast

8.2.1.    By Product Type

8.2.2.    By Technology

8.2.3.    By Disease Indication

8.2.4.    By Distribution Channel

8.2.5.    By End User

9.    East India Respiratory Inhalers Market Outlook

9.1.  Market Size & Forecast

9.1.1.    By Value

9.2.  Market Share & Forecast

9.2.1.    By Product Type

9.2.2.    By Technology

9.2.3.    By Disease Indication

9.2.4.    By Distribution Channel

9.2.5.    By End User

10. Market Dynamics

10.1.   Drivers

10.2.   Challenges

11. Market Trends & Developments

11.1.   Recent Development

11.2.   Mergers & Acquisitions

11.3.   Product Launches

12. India Respiratory Inhalers Market: SWOT Analysis

13. Porter’s Five Forces Analysis

13.1.   Competition in the Industry

13.2.   Potential of New Entrants

13.3.   Power of Suppliers

13.4.   Power of Customers

13.5.   Threat of Substitute Products

14. Competitive Landscape

14.1.   Philips India Limited

14.1.1. Business Overview

14.1.2.Company Snapshot

14.1.3. Products & Services

14.1.4.Financials (As Reported)

14.1.5.  Recent Developments

14.1.6. Key Personnel Details

14.1.7. SWOT Analysis

14.2.   Cipla Limited

14.3.   Teva API India Limited

14.4.   AstraZeneca Pharma India Limited

14.5.   GlaxoSmithKline Pharmaceuticals Limited

14.6.   Omron Healthcare India Private Limited

14.7.   Novartis India Limited

14.8.   3M India Limited

14.9.   Glenmark Pharmaceuticals Limited

14.10.Merck Life Science Private Limited

15.  Strategic Recommendations

16. About Us & Disclaimer

Figures and Tables

Frequently asked questions


The market size of the India Respiratory Inhalers Market is estimated to be USD 314.11 Million in 2024.


Philips India Limited, Cipla Limited, Teva API India Limited, AstraZeneca Pharma India Limited, GlaxoSmithKline Pharmaceuticals Limited, Omron Healthcare India Private Limited, Novartis India Limited, 3M India Limited, Glenmark Pharmaceuticals Limited, Merck Life Science Private Limited, are among the top market players operating in India Respiratory Inhalers Market.


The Western region of India is leading the India Respiratory Inhalers Market. Factors such as high pollution levels, increased smoking habits, and a higher prevalence of respiratory diseases in densely populated areas contribute to this dominance. Additionally, the presence of major pharmaceutical companies and better healthcare infrastructure also play a significant role.


Increasing prevalence of respiratory disorders and increasing adoption of smart inhalers technologies are the major drivers for the India Respiratory Inhalers Market.


Sakshi Bajaal

Business Consultant
Press Release

India Respiratory Inhalers Market to Grow with a CAGR of 7.45% through 2030

May, 2024

Increasing adoption of smart inhalers technologies and increasing prevalence of respiratory disorders is expected to drive the India Respiratory Inhalers Market growth in the forecast period, 2026-20